The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


IBANDRONIC ACID SANDOZ

50 Milligram Film Coated Tablet

Sandoz GmbHEU/1/11/685/001-005

Main Information

Trade NameIBANDRONIC ACID SANDOZ
Active SubstancesIBANDRONIC ACID
Strength50 Milligram
Dosage FormFilm Coated Tablet
Licence HolderSandoz GmbH
Licence NumberEU/1/11/685/001-005

Group Information

ATC CodeM05BA06 ibandronic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued26/07/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics,section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back